André Choulika, PhD, chief executive officer and cofounder, Cellectis, discussed the company’s expansion into gene therapies.
André Choulika, PhD
Advertisement
Articles by André Choulika, PhD
André Choulika, PhD, chief executive officer and cofounder, Cellectis, discussed the company’s partnerships and science.
André Choulika, PhD, chief executive officer and cofounder, Cellectis, discussed therapies the company is developing.
Advertisement
Latest Updated Articles
CAR T Therapies for Hematologic Malignancies and Solid TumorsPublished: October 14th 2021 | Updated:
- Collaborating to Develop Oncologic Cell Therapies
Published: October 26th 2021 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Naji Gehchan, MD, MBA, on Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: Future Predictions for the Field
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
